1. Home
  2. TOST vs HOLX Comparison

TOST vs HOLX Comparison

Compare TOST & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toast Inc.

TOST

Toast Inc.

HOLD

Current Price

$27.73

Market Cap

18.3B

Sector

Technology

ML Signal

HOLD

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$74.81

Market Cap

16.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOST
HOLX
Founded
2012
1985
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Electronics
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3B
16.6B
IPO Year
2021
1990

Fundamental Metrics

Financial Performance
Metric
TOST
HOLX
Price
$27.73
$74.81
Analyst Decision
Buy
Hold
Analyst Count
23
13
Target Price
$44.86
$77.89
AVG Volume (30 Days)
10.8M
2.6M
Earning Date
02-12-2026
01-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.43
2.40
Revenue
$5,858,000,000.00
$4,126,500,000.00
Revenue This Year
$26.19
$6.74
Revenue Next Year
$20.61
$5.48
P/E Ratio
$63.47
$31.08
Revenue Growth
25.76
2.17
52 Week Low
$26.92
$51.90
52 Week High
$49.66
$75.36

Technical Indicators

Market Signals
Indicator
TOST
HOLX
Relative Strength Index (RSI) 28.65 49.63
Support Level $26.92 $74.50
Resistance Level $32.17 $74.99
Average True Range (ATR) 1.19 0.43
MACD -0.58 -0.06
Stochastic Oscillator 10.98 82.79

Price Performance

Historical Comparison
TOST
HOLX

About TOST Toast Inc.

Toast is an end-to-end technology platform designed to address the complex needs of the restaurant industry. The company generates point-in-time revenue through sales of its restaurant-grade hardware and recurring revenue in the form of take rates on restaurant transaction volume as well as subscriptions to its software solutions. As of fiscal 2024, the company provided services to 134,000 restaurant locations primarily in the US. Toast's typical customer is a mid-market restaurant generating slightly more than $1 million in revenue annually.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: